Thomas Boesen — Management

Get alerts when Thomas Boesen trades

Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: SynAct Pharma AB.

12-month summary

Net buyer over the last 12 months

2 open-market buys, 0 sales, 0 share awards · SEK 97,610.00 bought, SEK 0.00 sold

Roles

SynAct Pharma AB Stockholm
Management
03.03.2026 – 03.03.2026

Transactions (including via associated entities)

DateIssuerTransaction typeVolumePriceValueSource
03.03.2026SynAct Pharma AB Stockholm
Bought — open marketAcquisition
via Boesen Biotech ApS
2,750SEK 17.92
SEK 49,280.00
↗
03.03.2026SynAct Pharma AB Stockholm
Bought — open marketAcquisition
via Boesen Biotech ApS
2,700SEK 17.90
SEK 48,330.00
↗